Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Metaba, LLC ( and MAX BioPharma, Inc. ( are pleased to announce significant progress in their collaboration to develop ...

According to the Global TB Report by WHO, India has seen a decline of 16 per cent in TB incidence (new cases emerging each ...

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

The tuberculosis outbreak in the Kansas City area is not, in fact, the largest in U.S. history. But it does offer an ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including Mycobacterium tuberculosis ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...

Römpp, A., Treu, A., Kokesch-Himmelreich, J. et al. The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis. Nat Commun 16, ...

A simple model projected which strains were likely to be highly transmissible, with implications for public health.